***PKTX.. Yes, It's a little old PR News.. But New PR News...Is Right Behind this..!
..If proven successful in human clinical trials, Shapiro believes the inclusion of AAGP..
Could soon become a permanent addition to the Edmonton Protocol, representing a significant step..
...Forward in the treatment of Type 1 diabetes through islet transplantation.
...While more research is needed, he also believes the drug shows promise for a wide range of transplantations..
..Potentially working to protect organs as effectively as it protects islets.
****Funding for the study was provided by the Diabetes Research Institute Foundation of Canada.
...While the drug AAGP, was provided in kind by Protokinetix -- a biotechnology company..
..That provides medical researchers assistance in enhancing cell survival and health.
The check is in the mail...
Posts: 129 | From: Florida | Registered: Dec 2009
| IP: Logged |